Secretagogue

TESA + IPA

5 mg + 5 mg per vial

TESA + IPA is a dual-peptide reference blend combining tesamorelin, a 44-amino-acid GHRH analog with an N-terminal trans-3-hexenoyl group, and ipamorelin, a pentapeptide growth-hormone secretagogue and selective ghrelin/GHS receptor agonist. Each 10 mL vial contains 5 mg of each peptide (10 mg total) as lyophilized powder.

Quantity

$99.99

Technical notes

Research Profile

Tesamorelin sequence: trans-3-hexenoyl-YADAIFTNSYRKVLGQLSARKLLQDIMSRQQGESNQERGARARL. Molecular formula C221H366N72O67S; molecular mass approximately 5,135.9 g/mol.

Ipamorelin sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH2. Molecular formula C38H49N9O5; molecular mass approximately 711.9 g/mol.

The blend pairs a GHRH-receptor agonist with a selective GHS-R1a agonist for growth-hormone-axis research models. Both components are supplied as laboratory reference material only, not for human or animal use.

Research context: GHRH/GHS synergy studies, pituitary signaling models, and secretagogue receptor-binding characterization.

Handling & reconstitution

Add the desired volume of bacteriostatic water slowly down the vial wall. For example, 2 mL yields 2.5 mg/mL of each peptide.

Lab assistant

AI Dosing & Reconstitution Assistant

Enter your vial, diluent, and target aliquot in any unit — mcg, mg, g, mL, µL, or U-100 syringe units. Every value is range-checked before generation, and the assistant returns concentration, draw volume, and a reconstitution workflow tailored to TESA + IPA.

Inputs are inside normal laboratory ranges: 2.5 mg/mL, draw 0.1 mL (10 U), ~20 aliquots per vial · aliquot = 250 mcg.

Draw volume in every unit: 0.1 mL · 100 µL · 10 U.

Target aliquot: 250 mcg · 0.25 mg · 0.0003 g.

Dosing schedule generator

Choose a cadence and a time window to lay out a day-by-day plan with per-day and cumulative totals, draw volumes, and vials required. Planning aid for laboratory record-keeping only.

1 aliquot every day

1 – 180 days

Aliquots
14

14 active / 0 rest days

Total mass (mcg)
3,500

250 mcg per aliquot

Total draw
1.4 mL

0.1 mL per aliquot

Vials required
0.7

stock 1 · 1 vial ≈ 14 days

DayDateTimesDaily (mcg)Draw (mL)Cumulative (mcg)Vials
1Aug 28, 2026 Fri08:002500.12500.05
2Aug 29, 2026 Sat08:002500.15000.1
3Aug 30, 2026 Sun08:002500.17500.15
4Aug 31, 2026 Mon08:002500.11,0000.2
5Sep 1, 2026 Tue08:002500.11,2500.25
6Sep 2, 2026 Wed08:002500.11,5000.3
7Sep 3, 2026 Thu08:002500.11,7500.35
8Sep 4, 2026 Fri08:002500.12,0000.4
9Sep 5, 2026 Sat08:002500.12,2500.45
10Sep 6, 2026 Sun08:002500.12,5000.5
11Sep 7, 2026 Mon08:002500.12,7500.55
12Sep 8, 2026 Tue08:002500.13,0000.6
13Sep 9, 2026 Wed08:002500.13,2500.65
14Sep 10, 2026 Thu08:002500.13,5000.7
Totals3,5001.43,5000.7

Planning aid · Research Use Only · not for human or veterinary administration

Protocol history

Saved protocols for this compound will appear here. Every generated dosing & reconstitution result is stored locally on this device so you can revisit or reprint an earlier version.

Saved calculations across every compound live on the calculation history page.

Literature

Research Citations

Curated entry points into the peer-reviewed record for this compound. Links open indexed searches at the U.S. National Library of Medicine so you can verify the current literature yourself rather than relying on a static citation list.

Compliance

TESA + IPA is supplied strictly as a laboratory reference material. It is not a drug, supplement, food, or cosmetic, and it is not for therapeutic or diagnostic use, human consumption, or veterinary use. Purchasers are responsible for handling the material in accordance with their institutional and jurisdictional requirements.

← Back to catalog

Customer reviews

Verified Feedback

Rating summary

Loading reviews…

Write a review

Your rating

All reviews are moderated before publication. Reviews describing human or veterinary use cannot be published.

    Shipping & Returns

    Delivery & Refund Policy

    Related Peptides

    Similar by category, dosage, or research focus.